Edition:
India

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

0.27USD
13 Jul 2020
Change (% chg)

-- (--)
Prev Close
$0.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
566,664
52-wk High
$1.13
52-wk Low
$0.20

Latest Key Developments (Source: Significant Developments)

Sunesis Pharmaceuticals Says Qtrly Loss Per Share $0.09
Thursday, 8 Aug 2019 

Aug 7 (Reuters) - Sunesis Pharmaceuticals Inc ::SUNESIS PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.SUNESIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.09.  Full Article

Sunesis Pharmaceuticals Reports Fourth Quarter Loss Per Share Of $0.16
Friday, 8 Mar 2019 

March 7 (Reuters) - Sunesis Pharmaceuticals Inc ::SUNESIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS.QTRLY LOSS PER SHARE $0.16.Q4 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA.  Full Article

Sunesis Announces Pricing Of $20 Mln Offering Of Securities
Friday, 18 Jan 2019 

Jan 17 (Reuters) - Sunesis Pharmaceuticals Inc ::SUNESIS ANNOUNCES PRICING OF $20 MILLION OFFERING OF SECURITIES.ANNOUNCED PRICING OF UNDERWRITTEN PUBLIC OFFERINGS OF 23 MILLION SHARES OF ITS COMMON STOCK AT $0.50.PRICING OF UNDERWRITTEN PUBLIC OFFERINGS OF 17,000 SHARES OF ITS NON-VOTING SERIES E CONVERTIBLE PREFERRED STOCK AT $500.SUNESIS EXPECTS TO RECEIVE COMBINED GROSS PROCEEDS OF APPROXIMATELY $20 MILLION FROM THESE OFFERINGS.  Full Article

Sunesis Pharmaceuticals Announces Proposed Public Offering Of Common Stock And Preferred Stock
Friday, 18 Jan 2019 

Jan 17 (Reuters) - Sunesis Pharmaceuticals Inc ::SUNESIS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PREFERRED STOCK.  Full Article

BRIEF-Sunesis Pharmaceuticals Plans To Review Strategic Alternatives

* SUNESIS PHARMACEUTICALS - REDUCTION IN WORKFORCE OF ABOUT 30% OF HEAD COUNT TO FOCUS ON DEVELOPMENT OF ITS FIRST-IN-CLASS PDK1 INHIBITOR SNS-510